Finance

Lists
Why is MANE down 2,40%?
Dive Deeper
MANE:NYSE
Veradermics Inc
113,47 US$
-2,40%
(-2,79) 1D
114,50 US$
+0,91% (+1,03)
Pre-market
Closed: 14 ოქტ, 16:00:02 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MANE...
Open
115,35 US$
High
118,91 US$
Low
112,62 US$
Mkt. cap
4,74 მლრდ.
Avg. vol.
836,64 ათ.
Volume
944,00
52-wk high
136,72 US$
52-wk low
32,00 US$
EPS
-3,35 US$
No. of employees
37
Open
115,35 US$
High
118,91 US$
Low
112,62 US$
Mkt. cap
4,74 მლრდ.
Avg. vol.
836,64 ათ.
Volume
944,00
52-wk high
136,72 US$
52-wk low
32,00 US$
EPS
-3,35 US$
No. of employees
37
News stories
From web sources and news partners
About Veradermics Inc
CEO-
Employees37
Founded2019
Headquartersნიუ-ჰეივენი, კონექტიკუტი, ამერიკის შეერთებული შტატები
SectorPharmaceutical industry
Websiteveradermics.com
Analyst ratings
Based on 4 analysts giving stock ratings to MANE in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for MANE in the last 3 months.
Highest
Current 113,47 US$
182,00 US$ (+60,39%)
Average
169,00 US$ (+48,94%)
Lowest
160,00 US$ (+41,01%)
Analyst
Recommendation
Action
Price target
Projected
Date
Geoff Meacham
Citi
Buy
Maintained
160,00 US$
+41%
09/15/2026
Roger Song
Jefferies
Buy
Maintained
182,00 US$
+60,4%
09/08/2026
Unknown Analyst
Jefferies
Buy
Maintained
182,00 US$
+60,4%
09/08/2026
Serge Belanger
Needham
Buy
Maintained
164,00 US$
+44,5%
08/12/2026
Rami Katkhuda
LifeSci Capital
Buy
Maintained
170,00 US$
+49,8%
08/11/2026
Mayank Mamtani
B. Riley Securities
Buy
Initiated
170,00 US$
+49,8%
07/15/2026
Marc Goodman
Leerink Partners
Buy
Initiated
75,00 US$
-33,9%
03/02/2026
Prakhar Agrawal
Cantor Fitzgerald
Buy
Initiated
-
-
03/01/2026
Last report
11 აგვ. 2026
Fiscal period
Q2 2026
-0,58 US$ / -0,64 US$
+9,56%beat
Revenue / Est. (USD)
- / 0,00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ივნ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
14,33 მლნ.
18,19 მლნ.
20,92 მლნ.
18,61 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,74 მლნ.
4,82 მლნ.
8,94 მლნ.
10,95 მლნ.
Operating expense
16,07 მლნ.
23,01 მლნ.
29,86 მლნ.
29,55 მლნ.
Total operating expenses
16,07 მლნ.
23,01 მლნ.
29,86 მლნ.
29,55 მლნ.
Operating income
-16,07 მლნ.
-23,01 მლნ.
-29,86 მლნ.
-29,55 მლნ.
Other non operating income
325,00 ათ.
258,00 ათ.
149,00 ათ.
1,21 მლნ.
EBT including unusual items
-15,64 მლნ.
-21,85 მლნ.
-27,23 მლნ.
-23,50 მლნ.
EBT excluding unusual items
-15,64 მლნ.
-21,85 მლნ.
-27,23 მლნ.
-23,50 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-15,64 მლნ.
-21,85 მლნ.
-27,23 მლნ.
-23,50 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-
-104,54
-1,32
-0,58
Interest and investment income
103,00 ათ.
906,00 ათ.
2,48 მლნ.
4,84 მლნ.
Interest expense
-
-
-
-
Net interest expenses
103,00 ათ.
906,00 ათ.
2,48 მლნ.
4,84 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები